Risk factor analysis and diagnosis and treatment of early portal vein complications after liver transplantation

Yingjie He, Wen Peihao, Zhang Jiakai, W. Zhihui, Shi Xiaoyi, Yu‐Ting He, Jie Li, Wenzhi Guo
{"title":"Risk factor analysis and diagnosis and treatment of early portal vein complications after liver transplantation","authors":"Yingjie He, Wen Peihao, Zhang Jiakai, W. Zhihui, Shi Xiaoyi, Yu‐Ting He, Jie Li, Wenzhi Guo","doi":"10.3760/CMA.J.ISSN.0254-1785.2019.11.003","DOIUrl":null,"url":null,"abstract":"Objective \nTo explore the risk factors, diagnosis and treatment of early portal vein complications after liver transplantation. \n \n \nMethods \nFrom January 2016 to December 2018, clinical data of 616 adult patients undergoing liver transplantation were retrospectively analyzed. Nine cases (1.5%) had early portal vein complications. By comparing the general status of recipients and donors and the intraoperative findings, the risk factors of early portal vein complications were analyzed. \n \n \nResults \nNo statistically significant differences existed in recipient age, gender, donor/recipient blood type, donor liver cold ischemia time, transplant operative duration, intraoperative non-hepatic period, intraoperative blood loss or intraoperative red blood cell transfusion (P>0.05). However, preoperative recipients had portal vein thrombosis, splenectomy, retransplantation and portal vein anastomosis. Statistical differences existed and all were risk factors for early portal vein complications (P<0.05). Binary logistic regression showed that preoperative patients had portal vein thrombosis [OR=16.922, 95% CI(1.859-154.059), P=0.012] and retransplantation [OR=64.871, 95% CI(8.293-507.435), P<0.001] was an independent risk factor for early portal vein complications. Nine cases of early portal vein complications were confirmed by ultrasound and/or computed tomography (CT) angiography. Three patients with portal vein thrombosis type 1 received oral medication while another three with portal vein thrombosis type 2 underwent abdominal portal vein incision, thrombectomy and large omental portal vein pump implantation. During a follow-up period of (22±14.8) months, portal vein blood flow remained patent. One patient with portal vein stenosis underwent portal vein balloon dilation and stent implantation. During a follow-up period of 17 months, portal vein blood flow remained patent. Two patients with abnormal portal vein blood flow underwent liver re-transplantation and died postoperatively. \n \n \nConclusions \nPreoperative portal vein thrombosis and splenectomy, re-transplantation of liver and end-to-end anastomosis of non-donor recipient portal vein are risk factors for early portal vein complications after liver transplantation. Individualized treatments of portal vein thrombosis may be provided according to the type of thrombus and liver function. And the prognosis is decent. Because of a higher mortality rate, attention should be paid to patients with abnormal portal vein blood flow immediately after re-transplantation. \n \n \nKey words: \nLiver transplantation; Portal complications; Risk factors; Diagnosis; Treatment; Prognosis","PeriodicalId":9885,"journal":{"name":"Chineae Journal of Organ Transplantation","volume":"3 1","pages":"660-664"},"PeriodicalIF":0.0000,"publicationDate":"2019-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chineae Journal of Organ Transplantation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.0254-1785.2019.11.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To explore the risk factors, diagnosis and treatment of early portal vein complications after liver transplantation. Methods From January 2016 to December 2018, clinical data of 616 adult patients undergoing liver transplantation were retrospectively analyzed. Nine cases (1.5%) had early portal vein complications. By comparing the general status of recipients and donors and the intraoperative findings, the risk factors of early portal vein complications were analyzed. Results No statistically significant differences existed in recipient age, gender, donor/recipient blood type, donor liver cold ischemia time, transplant operative duration, intraoperative non-hepatic period, intraoperative blood loss or intraoperative red blood cell transfusion (P>0.05). However, preoperative recipients had portal vein thrombosis, splenectomy, retransplantation and portal vein anastomosis. Statistical differences existed and all were risk factors for early portal vein complications (P<0.05). Binary logistic regression showed that preoperative patients had portal vein thrombosis [OR=16.922, 95% CI(1.859-154.059), P=0.012] and retransplantation [OR=64.871, 95% CI(8.293-507.435), P<0.001] was an independent risk factor for early portal vein complications. Nine cases of early portal vein complications were confirmed by ultrasound and/or computed tomography (CT) angiography. Three patients with portal vein thrombosis type 1 received oral medication while another three with portal vein thrombosis type 2 underwent abdominal portal vein incision, thrombectomy and large omental portal vein pump implantation. During a follow-up period of (22±14.8) months, portal vein blood flow remained patent. One patient with portal vein stenosis underwent portal vein balloon dilation and stent implantation. During a follow-up period of 17 months, portal vein blood flow remained patent. Two patients with abnormal portal vein blood flow underwent liver re-transplantation and died postoperatively. Conclusions Preoperative portal vein thrombosis and splenectomy, re-transplantation of liver and end-to-end anastomosis of non-donor recipient portal vein are risk factors for early portal vein complications after liver transplantation. Individualized treatments of portal vein thrombosis may be provided according to the type of thrombus and liver function. And the prognosis is decent. Because of a higher mortality rate, attention should be paid to patients with abnormal portal vein blood flow immediately after re-transplantation. Key words: Liver transplantation; Portal complications; Risk factors; Diagnosis; Treatment; Prognosis
肝移植术后早期门静脉并发症的危险因素分析及诊治
目的探讨肝移植术后早期门静脉并发症的危险因素、诊断及治疗。方法回顾性分析2016年1月至2018年12月616例成人肝移植患者的临床资料。早期门静脉并发症9例(1.5%)。通过比较供、受者的一般情况及术中发现,分析门静脉早期并发症的危险因素。结果受者年龄、性别、供/受血型、供肝冷缺血时间、移植手术时间、术中非肝期、术中出血量、术中红细胞输注量差异均无统计学意义(P>0.05)。然而,术前受者有门静脉血栓形成、脾切除、再移植和门静脉吻合。早期门静脉并发症的危险因素均有统计学差异(P<0.05)。二元logistic回归分析显示术前患者有门静脉血栓形成[OR=16.922, 95% CI(1.859-154.059), P=0.012],再移植[OR=64.871, 95% CI(8.293-507.435), P<0.001]是早期门静脉并发症的独立危险因素。9例早期门静脉并发症经超声和/或CT血管造影证实。1型门静脉血栓3例口服药物治疗,2型门静脉血栓3例行腹腔门静脉切开、取栓及大网膜门静脉泵植入术。随访(22±14.8)个月,门静脉血流通畅。1例门静脉狭窄患者行门静脉球囊扩张及门静脉支架置入术。随访17个月,门静脉血流通畅。2例门静脉血流异常患者行肝再移植手术,术后死亡。结论术前门静脉血栓形成及脾切除、肝脏再移植及非供受体门静脉端对端吻合是肝移植术后早期门静脉并发症的危险因素。门静脉血栓形成可根据血栓类型和肝功能进行个体化治疗。而且预后还不错。由于死亡率较高,再次移植后立即出现门静脉血流异常的患者应引起重视。关键词:肝移植;门户的并发症;风险因素;诊断;治疗;预后
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信